ABSTRACT
Ocular rosacea is a chronic potentially sight-threatening inflammatory condition, which can occur in approximately 20% of patients without skin involvement. However, an accurate diagnosis of ocular rosacea has not been defined yet due to its rather nonspecific symptoms and clinical findings. Therefore, this article updates the current recommendations for diagnosis and treatment of ocular rosacea and the previously published consensus recommendations from the ROSCO expert panel on the management of rosacea.
Disclosure statement
No potential conflict of interest was reported by the author(s).
Author contributions
All authors (BS, MS and MZ) contributed to all of the following:
conception and design of the work, acquisition of data or analysis and interpretation of data,
drafting the article or revising it critically for important intellectual content,
final approval of the version to be published and
agreement to be accountable for all aspects of the work